Very High Levels of High-Density Lipoprotein Cholesterol and Cardiovascular Events in Japanese Population.

Hirokazu Honda, Tsutomu Hirano, Masashi Ueda, Shiho Kojima, Shinichi Mashiba, Yasuyuki Hayase, Tetsuo Michihata, Takanori Shibata, High-Density Lipoprotein Subfractions and Their Oxidized Subfraction Particles in Patients with Chronic Kidney Disease. Journal of Atherosclerosis and Thrombosis. ,vol. 23, pp. 81- 94 ,(2016) , 10.5551/JAT.30015

Shizuya Yamashita, Kazumi Tsubakio-Yamamoto, Tohru Ohama, Yumiko Nakagawa-Toyama, Makoto Nishida, Molecular mechanisms of HDL-cholesterol elevation by statins and its effects on HDL functions. Journal of Atherosclerosis and Thrombosis. ,vol. 17, pp. 436- 451 ,(2010) , 10.5551/JAT.5405

Ramachandran S. Vasan, Michael J. Pencina, Sander J. Robins, Justin P. Zachariah, Guneet Kaur, Ralph B. D'Agostino, Jose M. Ordovas, Association of Circulating Cholesteryl Ester Transfer Protein Activity With Incidence of Cardiovascular Disease in the Community Circulation. ,vol. 120, pp. 2414- 2420 ,(2009) , 10.1161/CIRCULATIONAHA.109.872705

Sander J. Robins, Asya Lyass, Robert W. Brocia, Joseph M. Massaro, Ramachandran S. Vasan, Plasma lipid transfer proteins and cardiovascular disease. The Framingham Heart Study Atherosclerosis. ,vol. 228, pp. 230- 236 ,(2013) , 10.1016/J.ATHEROSCLEROSIS.2013.01.046

Philip J Barter, Mark Caulfield, Mats Eriksson, Scott M Grundy, John JP Kastelein, Michel Komajda, Jose Lopez-Sendon, Lori Mosca, Jean-Claude Tardif, David D Waters, Charles L Shear, James H Revkin, Kevin A Buhr, Marian R Fisher, Alan R Tall, Bryan Brewer, None, Effects of Torcetrapib in Patients at High Risk for Coronary Events The New England Journal of Medicine. ,vol. 357, pp. 2109- 2122 ,(2007) , 10.1056/NEJMOA0706628

Amit V. Khera, Marina Cuchel, Margarita de la Llera-Moya, Amrith Rodrigues, Megan F. Burke, Kashif Jafri, Benjamin C. French, Julie A. Phillips, Megan L. Mucksavage, Robert L. Wilensky, Emile R. Mohler, George H. Rothblat, Daniel J. Rader, Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis The New England Journal of Medicine. ,vol. 364, pp. 127- 135 ,(2011) , 10.1056/NEJMOA1001689

Tamio Teramoto, Jun Sasaki, Shun Ishibashi, Sadatoshi Birou, Hiroyuki Daida, Seitaro Dohi, Genshi Egusa, Takafumi Hiro, Kazuhiko Hirobe, Mami Iida, Shinji Kihara, Makoto Kinoshita, Chizuko Maruyama, Takao Ohta, Tomonori Okamura, Shizuya Yamashita, Masayuki Yokode, Koutaro Yokote, Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan —2012 Version Journal of Atherosclerosis and Thrombosis. ,vol. 20, pp. 517- 523 ,(2013) , 10.5551/JAT.15792

Tavia Gordon, William P. Castelli, Marthana C. Hjortland, William B. Kannel, Thomas R. Dawber, High density lipoprotein as a protective factor against coronary heart disease The American Journal of Medicine. ,vol. 62, pp. 707- 714 ,(1977) , 10.1016/0002-9343(77)90874-9

Gregory G Schwartz, Anders G Olsson, Markus Abt, Christie M Ballantyne, Philip J Barter, Jochen Brumm, Bernard R Chaitman, Ingar M Holme, David Kallend, Lawrence A Leiter, Eran Leitersdorf, John JV McMurray, Hardi Mundl, Stephen J Nicholls, Prediman K Shah, Jean-Claude Tardif, R Scott Wright, Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome The New England Journal of Medicine. ,vol. 367, pp. 2089- 2099 ,(2012) , 10.1056/NEJMOA1206797

S Zhong, D S Sharp, J S Grove, C Bruce, K Yano, J D Curb, A R Tall, Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. Journal of Clinical Investigation. ,vol. 97, pp. 2917- 2923 ,(1996) , 10.1172/JCI118751